Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 4 de 4
Filtrar
1.
Gene Ther ; 23(4): 380-92, 2016 Apr.
Artículo en Inglés | MEDLINE | ID: mdl-26836117

RESUMEN

Adeno-associated virus (AAV) vectors are showing promise in gene therapy trials and have proven to be extremely efficient biological tools in basic neuroscience research. One major limitation to their widespread use in the neuroscience laboratory is the cost, labor, skill and time-intense purification process of AAV. We have recently shown that AAV can associate with exosomes (exo-AAV) when the vector is isolated from conditioned media of producer cells, and the exo-AAV is more resistant to neutralizing anti-AAV antibodies compared with standard AAV. Here, we demonstrate that simple pelleting of exo-AAV from media via ultracentrifugation results in high-titer vector preparations capable of efficient transduction of central nervous system (CNS) cells after systemic injection in mice. We observed that exo-AAV is more efficient at gene delivery to the brain at low vector doses relative to conventional AAV, even when derived from a serotype that does not normally efficiently cross the blood-brain barrier. Similar cell types were transduced by exo-AAV and conventionally purified vector. Importantly, no cellular toxicity was noted in exo-AAV-transduced cells. We demonstrated the utility and robustness of exo-AAV-mediated gene delivery by detecting direct GFP fluorescence after systemic injection, allowing three-dimensional reconstruction of transduced Purkinje cells in the cerebellum using ex vivo serial two-photon tomography. The ease of isolation combined with the high efficiency of transgene expression in the CNS, may enable the widespread use of exo-AAV as a neuroscience research tool. Furthermore, the ability of exo-AAV to evade neutralizing antibodies while still transducing CNS after peripheral delivery is clinically relevant.


Asunto(s)
Dependovirus/genética , Exosomas , Terapia Genética/métodos , Vectores Genéticos/genética , Animales , Anticuerpos Neutralizantes/inmunología , Barrera Hematoencefálica/metabolismo , Encéfalo/metabolismo , Línea Celular , Técnicas de Transferencia de Gen , Humanos , Ratones , Transducción Genética , Transgenes
4.
Am Ind Hyg Assoc J ; 55(4): 352-7, 1994 Apr.
Artículo en Inglés | MEDLINE | ID: mdl-8209841

RESUMEN

This paper summarizes the reproductive health component of the AT&T Bell Laboratories occupational health program. The comprehensive R&D Reproductive Health Program is a collaborative effort between the Health Services Group and the Environmental Health & Safety Center. It provides a tailored curriculum to occupational health nurses and physicians so that they may respond to employee questions and concerns with detailed information and with referrals to appropriate subject-matter experts. Expanding on the typical regulatory approaches of hazard communication and right-to-know, the program encourages employees of both sexes to learn about workplace, environmental, and lifestyle aspects of reproductive and developmental health.


Asunto(s)
Industria Química , Promoción de la Salud/organización & administración , Enfermedades Profesionales/prevención & control , Exposición Profesional , Servicios de Salud del Trabajador/organización & administración , Complicaciones del Embarazo/prevención & control , Confidencialidad , Femenino , Sustancias Peligrosas/análisis , Humanos , Capacitación en Servicio , Entrevistas como Asunto , Masculino , New Jersey , Enfermería del Trabajo/educación , Medicina del Trabajo/educación , Embarazo , Estados Unidos , United States Occupational Safety and Health Administration
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA